These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 2331795)

  • 1. Postnatal development of striatal dopamine function. I. An examination of D1 and D2 receptors, adenylate cyclase regulation and presynaptic dopamine markers.
    Broaddus WC; Bennett JP
    Brain Res Dev Brain Res; 1990 Mar; 52(1-2):265-71. PubMed ID: 2331795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postnatal development of striatal dopamine function. II. Effects of neonatal 6-hydroxydopamine treatments on D1 and D2 receptors, adenylate cyclase activity and presynaptic dopamine function.
    Broaddus WC; Bennett JP
    Brain Res Dev Brain Res; 1990 Mar; 52(1-2):273-7. PubMed ID: 2110042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Developmental and age-related changes in D1-dopamine receptors and dopamine content in the rat striatum.
    Giorgi O; De Montis G; Porceddu ML; Mele S; Calderini G; Toffano G; Biggio G
    Brain Res; 1987 Oct; 432(2):283-90. PubMed ID: 2960426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopamine receptors in canine caudate nucleus.
    Maeno H
    Mol Cell Biochem; 1982 Mar; 43(2):65-80. PubMed ID: 6123940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influences of pertussis toxin, guanine nucleotides and forskolin on adenylate cyclase in striatal membranes of infant, adult and senescent rats.
    Nomura Y; Arima T; Swgawa T
    Int J Dev Neurosci; 1987; 5(3):271-9. PubMed ID: 3503504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pertussis toxin attenuates D2 inhibition and enhances D1 stimulation of adenylate cyclase by dopamine in rat striatum.
    Olianas MC; Onali P
    J Neurochem; 1987 May; 48(5):1443-7. PubMed ID: 2951497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential ontogeny of functional dopamine and muscarinic receptors mediating presynaptic inhibition of neurotransmitter release and postsynaptic regulation of adenylate cyclase activity in rat striatum.
    De Vries TJ; Mulder AH; Schoffelmeer AN
    Brain Res Dev Brain Res; 1992 Mar; 66(1):91-6. PubMed ID: 1350950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoradiographic identification of D1 dopamine receptors labelled with [3H]dopamine: distribution, regulation and relationship to coupling.
    Hervé D; Trovero F; Blanc G; Glowinski J; Tassin JP
    Neuroscience; 1992; 46(3):687-700. PubMed ID: 1532052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential modulation of D1 and D2 dopamine-sensitive adenylate cyclases by 17 beta-estradiol in cultured striatal neurons and anterior pituitary cells.
    Maus M; Bertrand P; Drouva S; Rasolonjanahary R; Kordon C; Glowinski J; Premont J; Enjalbert A
    J Neurochem; 1989 Feb; 52(2):410-8. PubMed ID: 2521359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative development of D1-dopamine and mu opiate receptors in normal and in 6-hydroxydopamine-lesioned neonatal rat striatum: dopaminergic fibers regulate mu but not D1 receptor distribution.
    Caboche J; Rogard M; Besson MJ
    Brain Res Dev Brain Res; 1991 Jan; 58(1):111-22. PubMed ID: 1849802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neonatal dopamine lesion in the rat results in enhanced adenylate cyclase activity without altering dopamine receptor binding or dopamine- and adenosine 3':5'-monophosphate-regulated phosphoprotein (DARPP-32) immunoreactivity.
    Luthman J; Lindqvist E; Young D; Cowburn R
    Exp Brain Res; 1990; 83(1):85-95. PubMed ID: 1981564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding sites for [3H]SCH 23390 in retina: properties and possible relationship to dopamine D1-receptors mediating stimulation of adenylate cyclase.
    Makman MH; Dvorkin B
    Brain Res; 1986 Dec; 387(3):261-70. PubMed ID: 2950967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Forskolin potentiates the stimulation of rat striatal adenylate cyclase mediated by D-1 dopamine receptors, guanine nucleotides, and sodium fluoride.
    Battaglia G; Norman AB; Hess EJ; Creese I
    J Neurochem; 1986 Apr; 46(4):1180-5. PubMed ID: 3005508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo partial inactivation of dopamine D1 receptors induces hypersensitivity of cortical dopamine-sensitive adenylate cyclase: permissive role of alpha 1-adrenergic receptors.
    Trovero F; Hervé D; Blanc G; Glowinski J; Tassin JP
    J Neurochem; 1992 Jul; 59(1):331-7. PubMed ID: 1351927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute in vivo amphetamine produces a homologous desensitization of dopamine receptor-coupled adenylate cyclase activities and decreases agonist binding to the D1 site.
    Roseboom PH; Gnegy ME
    Mol Pharmacol; 1989 Jan; 35(1):139-47. PubMed ID: 2563306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of D1 and D2 dopamine receptors and associated second messenger systems in fetal striatal transplants.
    Helm GA; Robertson MW; Jallo GI; Simmons N; Bennett JP
    Exp Neurol; 1991 Feb; 111(2):181-9. PubMed ID: 1703498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential response of striatal dopamine and muscarinic cholinergic receptor subtypes to the loss of dopamine. II. Effects of 6-hydroxydopamine or colchicine microinjections into the VTA or reserpine treatment.
    Joyce JN
    Exp Neurol; 1991 Sep; 113(3):277-90. PubMed ID: 1833220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Localization of nigrostriatal dopamine receptor subtypes and adenylate cyclase.
    Filloux F; Dawson TM; Wamsley JK
    Brain Res Bull; 1988 Apr; 20(4):447-59. PubMed ID: 3135077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. There is a limited critical period for dopamine's effects on D1 receptor expression in the developing rat neostriatum.
    Thomas WS; Neal-Beliveau BS; Joyce JN
    Brain Res Dev Brain Res; 1998 Nov; 111(1):99-106. PubMed ID: 9804909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential response of striatal dopamine and muscarinic cholinergic receptor subtypes to the loss of dopamine. I. Effects of intranigral or intracerebroventricular 6-hydroxydopamine lesions of the mesostriatal dopamine system.
    Joyce JN
    Exp Neurol; 1991 Sep; 113(3):261-76. PubMed ID: 1833219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.